Management of Alcohol Withdrawal Syndrome
Benzodiazepines are the cornerstone of alcohol withdrawal syndrome (AWS) treatment, with thiamine supplementation mandatory for all patients to prevent Wernicke encephalopathy. 1
Initial Assessment and Risk Stratification
Evaluate for serious complications requiring inpatient admission, including: 1
- History of withdrawal seizures or delirium tremens
- Significant AWS symptoms
- High levels of recent drinking
- Serious medical comorbidities (liver failure, respiratory failure, head trauma, renal failure)
- Serious psychiatric illness
- Failed outpatient treatment
Important caveat: While CIWA scoring helps assess severity and guide treatment, it should not be used for diagnosis of AWS, as high scores can occur in other conditions (anxiolytic withdrawal, anxiety disorders, sepsis, hepatic encephalopathy, severe pain). 1
Monitor vital signs frequently and evaluate for comorbidities: dehydration, electrolyte imbalance (especially magnesium), infection, gastrointestinal bleeding, pancreatitis. 1
Pharmacological Management
Benzodiazepines (First-Line Treatment)
For most patients: Use long-acting benzodiazepines (chlordiazepoxide 25-100 mg PO every 4-6 hours OR diazepam 5-10 mg PO/IV/IM every 6-8 hours) for seizure prevention and symptom control. 1
For patients with severe liver disease, advanced age, recent head trauma, respiratory failure, or obesity: Switch to lorazepam 1-4 mg PO/IV/IM every 4-8 hours (starting dose 6-12 mg/day), tapered after symptom resolution. 1 This recommendation is based on lorazepam's reduced dependence on hepatic metabolism, though evidence notes that all benzodiazepines are affected by hepatic insufficiency to some degree. 2
Critical point: More than 70% of cirrhotic patients may not require benzodiazepines at all—prescribe only when symptoms warrant treatment. 2 In severe liver disease, use a more gradual dose escalation. 2
Thiamine Supplementation (Mandatory)
All patients with AWS must receive thiamine 100-300 mg/day, maintained for 2-3 months after withdrawal symptom resolution. 1
Critical timing: Administer thiamine before giving IV fluids containing glucose, as glucose administration can precipitate acute thiamine deficiency and Wernicke encephalopathy. 1
For established Wernicke encephalopathy: 100-500 mg/day for 12-24 weeks. 1
Adjunctive Medications
Carbamazepine 200 mg PO every 6-8 hours: Alternative to benzodiazepines, effective for seizure prevention. 1
Haloperidol 0.5-5 mg PO every 8-12 hours or 2-5 mg IM: Use carefully as adjunctive therapy only for agitation or psychotic symptoms (hallucinations) not controlled by benzodiazepines. 1
Supportive Care
Provide: 1
- Adequate hydration and IV fluids
- Electrolyte replacement (especially magnesium)
- Vitamins
- Comfortable, quiet environment
Monitoring and Follow-up
Outpatient management is appropriate for mild-to-moderate withdrawal without risk factors, and is cost-effective with similar 6-month abstinence rates compared to inpatient care. 1
Monitor daily for up to 5 days after last drink to verify symptom improvement and assess need for additional treatment. 3
Psychiatric Consultation and Long-term Planning
Psychiatric consultation is strongly recommended for evaluation, acute AWS management, and long-term abstinence planning. 1 This addresses both the immediate withdrawal and the underlying alcohol use disorder, which is essential for preventing recurrence and improving long-term outcomes.
Common Pitfalls
Distinguishing alcohol withdrawal delirium from hepatic encephalopathy can be challenging but is critical. Delirium tremens typically peaks at 3-5 days post-cessation with autonomic hyperactivity (fever, tachycardia, hypertension, sweating), altered mental status, and disorientation. 1, 4
Alcohol withdrawal seizures are a rebound phenomenon requiring benzodiazepines, not anticonvulsants—distinguish from true epileptic seizures. 1